AVXL vs BSX · $247.4M cap vs P/E 20, rev $20.07B
Anavex Life Sciences Corp (AVXL) versus Boston Scientific Corp (BSX) — a side-by-side from cached financials, not a winner call.
Anavex Life Sciences Corp (AVXL) is a biotechnology company listed on NASDAQ.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
AVXL does not have a complete income-statement cache yet.
Latest reported BSX revenue for 2025-12-31 was $20.07B. Net income was $2.89B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
AVXL currently screens at market cap $247.4M. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Not investment advice. Open the AVXL and BSX stock pages for the full models.
Not investment advice.